Literature DB >> 17418634

Comparative study on digestive lipase activities on the self emulsifying excipient Labrasol, medium chain glycerides and PEG esters.

Sylvie Fernandez1, Vincent Jannin, Jean-David Rodier, Nicolas Ritter, Bruno Mahler, Frédéric Carrière.   

Abstract

Labrasol is a lipid-based self-emulsifying excipient used in the preparation of lipophilic drugs intended for oral delivery. It is mainly composed of PEG esters and glycerides with medium acyl chains, which are potential substrates for digestive lipases. The hydrolysis of Labrasol by porcine pancreatic extracts, human pancreatic juice and several purified digestive lipases was investigated in the present study. Classical human pancreatic lipase (HPL) and porcine pancreatic lipase, which are the main lipases involved in the digestion of dietary triglycerides, showed very low levels of activity on the entire Labrasol excipient as well as on separated fractions of glycerides and PEG esters. On the other hand, gastric lipase, pancreatic lipase-related protein 2 (PLRP2) and carboxyl ester hydrolase (CEH) showed high specific activities on Labrasol. These lipases were found to hydrolyze the main components of Labrasol (PEG esters and monoglycerides) used as individual substrates, whereas these esters were found to be poor substrates for HPL. The lipolytic activity of pancreatic extracts and human pancreatic juice on Labrasol(R) is therefore mainly due to the combined action of CEH and PLRP2. These two pancreatic enzymes, together with gastric lipase, are probably the main enzymes involved in the in vivo lipolysis of Labrasol taken orally.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17418634     DOI: 10.1016/j.bbalip.2007.02.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

Review 1.  Effects of surfactants on lipase structure, activity, and inhibition.

Authors:  Vincent Delorme; Rabeb Dhouib; Stéphane Canaan; Frédéric Fotiadu; Frédéric Carrière; Jean-François Cavalier
Journal:  Pharm Res       Date:  2011-01-14       Impact factor: 4.200

2.  A broad pH range indicator-based spectrophotometric assay for true lipases using tributyrin and tricaprylin.

Authors:  María de Los Angeles Camacho-Ruiz; Juan Carlos Mateos-Díaz; Frédéric Carrière; Jorge A Rodriguez
Journal:  J Lipid Res       Date:  2015-03-07       Impact factor: 5.922

3.  Insights into drug precipitation kinetics during in vitro digestion of a lipid-based drug delivery system using in-line raman spectroscopy and mathematical modeling.

Authors:  Cordula Stillhart; Georgios Imanidis; Martin Kuentz
Journal:  Pharm Res       Date:  2013-02-28       Impact factor: 4.200

4.  Biopharmaceutical modeling of drug supersaturation during lipid-based formulation digestion considering an absorption sink.

Authors:  Cordula Stillhart; Georgios Imanidis; Brendan T Griffin; Martin Kuentz
Journal:  Pharm Res       Date:  2014-06-25       Impact factor: 4.200

Review 5.  Lipids in the Stomach - Implications for the Evaluation of Food Effects on Oral Drug Absorption.

Authors:  Mirko Koziolek; Frédéric Carrière; Christopher J H Porter
Journal:  Pharm Res       Date:  2018-02-08       Impact factor: 4.200

6.  Toward the establishment of standardized in vitro tests for lipid-based formulations, part 6: effects of varying pancreatin and calcium levels.

Authors:  Philip Sassene; Karen Kleberg; Hywel D Williams; Jean-Claude Bakala-N'Goma; Frédéric Carrière; Marilyn Calderone; Vincent Jannin; Annabel Igonin; Anette Partheil; Delphine Marchaud; Eduardo Jule; Jan Vertommen; Mario Maio; Ross Blundell; Hassan Benameur; Christopher J H Porter; Colin W Pouton; Anette Müllertz
Journal:  AAPS J       Date:  2014-10-02       Impact factor: 4.009

7.  Synthesis and kinetic evaluation of cyclophostin and cyclipostins phosphonate analogs as selective and potent inhibitors of microbial lipases.

Authors:  Vanessa Point; Raj K Malla; Sadia Diomande; Benjamin P Martin; Vincent Delorme; Frederic Carriere; Stephane Canaan; Nigam P Rath; Christopher D Spilling; Jean-François Cavalier
Journal:  J Med Chem       Date:  2012-11-07       Impact factor: 7.446

8.  In vitro gastrointestinal lipolysis of four formulations of piroxicam and cinnarizine with the self emulsifying excipients Labrasol and Gelucire 44/14.

Authors:  Sylvie Fernandez; Stéphanie Chevrier; Nicolas Ritter; Bruno Mahler; Frédéric Demarne; Frédéric Carrière; Vincent Jannin
Journal:  Pharm Res       Date:  2009-05-19       Impact factor: 4.200

9.  Lipid-based formulations for danazol containing a digestible surfactant, Labrafil M2125CS: in vivo bioavailability and dynamic in vitro lipolysis.

Authors:  Anne Larsen; René Holm; Mette Lund Pedersen; Anette Müllertz
Journal:  Pharm Res       Date:  2008-07-01       Impact factor: 4.200

10.  Toward the establishment of standardized in vitro tests for lipid-based formulations. 5. Lipolysis of representative formulations by gastric lipase.

Authors:  Jean-Claude Bakala-N'Goma; Hywel D Williams; Philip J Sassene; Karen Kleberg; Marilyn Calderone; Vincent Jannin; Annabel Igonin; Anette Partheil; Delphine Marchaud; Eduardo Jule; Jan Vertommen; Mario Maio; Ross Blundell; Hassan Benameur; Anette Müllertz; Colin W Pouton; Christopher J H Porter; Frédéric Carrière
Journal:  Pharm Res       Date:  2014-10-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.